Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors

M.H.G. Langenberg, C.M. van Herpen, J. de Bono, J.H.M. Schellens, C Unger, K. Hoekman, H.E. Blum, W. Fiedler, J. Drevs, F. le Maulf, A. Fielding, J. Robertson, E.E. Voest

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science